Total Payments
$4,440
2024 Payments
$259.37
Companies
14
Transactions
77
Medicare Patients
8,581
Medicare Billing
$573,852
Payment Breakdown by Category
Food & Beverage$3,474 (78.2%)
Travel$928.36 (20.9%)
Education$38.00 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,474 | 73 | 78.2% |
| Travel and Lodging | $928.36 | 3 | 20.9% |
| Education | $38.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pulmonx Corporation | $1,369 | 9 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,324 | 33 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $520.05 | 7 | $0 (2024) |
| Genentech USA, Inc. | $479.57 | 9 | $0 (2023) |
| Intuitive Surgical, Inc. | $189.42 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $149.05 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $138.54 | 2 | $0 (2022) |
| ABIOMED | $135.97 | 1 | $0 (2020) |
| Mylan Specialty L.P. | $44.25 | 3 | $0 (2023) |
| Masimo Corporation | $28.86 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $259.37 | 4 | GlaxoSmithKline, LLC. ($135.11) |
| 2023 | $2,115 | 30 | Pulmonx Corporation ($1,369) |
| 2022 | $756.67 | 27 | GlaxoSmithKline, LLC. ($340.50) |
| 2021 | $273.62 | 5 | GlaxoSmithKline, LLC. ($229.57) |
| 2020 | $135.97 | 1 | ABIOMED ($135.97) |
| 2019 | $122.63 | 1 | AstraZeneca Pharmaceuticals LP ($122.63) |
| 2018 | $757.59 | 8 | Genentech USA, Inc. ($400.72) |
| 2017 | $19.28 | 1 | Covidien LP ($19.28) |
All Payment Transactions
77 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $124.26 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $7.13 | General |
| Category: RESPIRATORY | ||||||
| 06/05/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $122.60 | General |
| Category: VACCINES | ||||||
| 01/10/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: RESPIRATORY | ||||||
| 11/09/2023 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device), PULMONX CHARTIS TABLET CONSOLE, CHARTIS CATHETER | Travel and Lodging | Cash or cash equivalent | $304.07 | General |
| Category: PULMONOLOGY | ||||||
| 11/09/2023 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device), PULMONX CHARTIS TABLET CONSOLE, CHARTIS CATHETER | Food and Beverage | Cash or cash equivalent | $97.16 | General |
| Category: PULMONOLOGY | ||||||
| 10/11/2023 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device), PULMONX CHARTIS TABLET CONSOLE, CHARTIS CATHETER | Travel and Lodging | Cash or cash equivalent | $81.70 | General |
| Category: PULMONOLOGY | ||||||
| 10/10/2023 | Pulmonx Corporation | ZEPHYR ENDOBRONCHIAL VALVE (Device), PULMONX CHARTIS TABLET CONSOLE, CHARTIS CATHETER | Travel and Lodging | Cash or cash equivalent | $542.59 | General |
| Category: PULMONOLOGY | ||||||
| 10/09/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $52.81 | General |
| 10/08/2023 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), ZEPHYR ENDOBRONCHIAL VALVE, PULMONX CHARTIS TABLET CONSOLE | Food and Beverage | In-kind items and services | $135.92 | General |
| Category: PULMONOLOGY | ||||||
| 10/08/2023 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), PULMONX CHARTIS TABLET CONSOLE, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: PULMONOLOGY | ||||||
| 10/04/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $88.44 | General |
| Category: PULMONOLOGY | ||||||
| 09/26/2023 | Pulmonx Corporation | ZEPHYR DELIVERY CATHETER (Device), PULMONX CHARTIS TABLET CONSOLE, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: PULMONOLOGY | ||||||
| 09/25/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $91.25 | General |
| Category: PULMONOLOGY | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.27 | General |
| Category: IMMUNOLOGY | ||||||
| 09/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $40.26 | General |
| Category: RESPIRATORY | ||||||
| 08/31/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $106.00 | General |
| Category: Respiratory | ||||||
| 08/14/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $109.26 | General |
| Category: IMMUNOLOGY | ||||||
| 08/04/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $10.48 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.37 | General |
| Category: Respiratory | ||||||
| 06/29/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.90 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.57 | General |
| Category: IMMUNOLOGY | ||||||
| 04/25/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $5.98 | General |
| Category: IMMUNOLOGY | ||||||
| 03/21/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $90.42 | General |
| Category: SURGERY | ||||||
| 03/02/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $120.60 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,713 | 1,988 | $393,731 | $129,116 |
| 2022 | 28 | 2,493 | 2,907 | $512,521 | $161,550 |
| 2021 | 27 | 2,383 | 2,705 | $428,807 | $140,268 |
| 2020 | 32 | 1,992 | 2,380 | $407,899 | $142,918 |
Total Patients
8,581
Total Services
9,980
Medicare Billing
$573,852
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 86 | 146 | $63,367 | $24,510 | 38.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 171 | 305 | $46,575 | $19,098 | 41.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 83 | 112 | $25,184 | $10,501 | 41.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 84 | 88 | $23,154 | $8,932 | 38.6% |
| 31629 | Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope | Facility | 2023 | 58 | 58 | $31,409 | $7,110 | 22.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 51 | 52 | $18,784 | $6,575 | 35.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 149 | 166 | $15,260 | $6,501 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 68 | 84 | $15,600 | $6,116 | 39.2% |
| 31652 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 1-2 lymph nodes | Facility | 2023 | 44 | 45 | $19,755 | $5,501 | 27.8% |
| 31627 | Computer-assisted image-guided navigation of lung airways using an endoscope | Facility | 2023 | 58 | 58 | $11,055 | $4,216 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 32 | 35 | $9,601 | $3,891 | 40.5% |
| 31653 | Exam of lung airways and sampling of lymph nodes using an endoscope and ultrasound guidance, 3 or more lymph nodes | Facility | 2023 | 19 | 19 | $9,150 | $3,632 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $8,483 | $3,092 | 36.5% |
| 31654 | Exam of lung airways with diagnostic or therapeutic procedure on growths using an endoscope and ultrasound | Facility | 2023 | 59 | 59 | $7,850 | $2,915 | 37.1% |
| 32555 | Aspiration of fluid from chest cavity using imaging guidance | Facility | 2023 | 28 | 32 | $6,944 | $2,627 | 37.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 46 | 48 | $6,064 | $2,515 | 41.5% |
| 31628 | Biopsy of lobe of lung using an endoscope, 1 lobe | Facility | 2023 | 62 | 62 | $26,054 | $2,486 | 9.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 14 | 14 | $4,922 | $2,010 | 40.8% |
| 32557 | Drainage of fluid from chest cavity with insertion of indwelling tube using imaging guidance | Facility | 2023 | 12 | 12 | $3,642 | $1,409 | 38.7% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 133 | 134 | $3,332 | $1,118 | 33.5% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 62 | 63 | $2,838 | $964.70 | 34.0% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 136 | 137 | $2,445 | $862.58 | 35.3% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 59 | 59 | $25,713 | $812.19 | 3.2% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 105 | 106 | $3,358 | $759.70 | 22.6% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $2,050 | $658.60 | 32.1% |
About Dr. Stephen Gegick, MD
Dr. Stephen Gegick, MD is a Internal Medicine healthcare provider based in Virginia Beach, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245405992.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Gegick, MD has received a total of $4,440 in payments from pharmaceutical and medical device companies, with $259.37 received in 2024. These payments were reported across 77 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($3,474).
As a Medicare-enrolled provider, Gegick has provided services to 8,581 Medicare beneficiaries, totaling 9,980 services with total Medicare billing of $573,852. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease, Critical Care Medicine
- Location Virginia Beach, VA
- Active Since 04/24/2008
- Last Updated 07/05/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1245405992
Products in Payments
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $1,026
- NUCALA (Biological) $925.61
- TEZSPIRE (Biological) $357.67
- TRELEGY ELLIPTA (Drug) $210.72
- Da Vinci Surgical System (Device) $189.42
- CHARTIS CATHETER (Device) $179.69
- Esbriet (Biological) $174.45
- ZEPHYR DELIVERY CATHETER (Device) $164.17
- Impella (Device) $135.97
- IMFINZI (Drug) $122.63
- SHINGRIX (Biological) $122.60
- OFEV (Drug) $105.11
- Xolair (Biological) $78.85
- STIOLTO RESPIMAT (Drug) $43.94
- FASENRA (Biological) $39.75
- Patient SafetyNet System (Device) $28.86
- Yupelri (Drug) $28.59
- XOLAIR (Biological) $24.85
- superDimension (Device) $19.28
- YUPELRI (Drug) $15.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Virginia Beach
Dr. Garfield Samuels, M.d, M.D
Internal Medicine — Payments: $144,009
Internal Medicine $144,009
Anthony Amabile, Md, MD
Internal Medicine — Payments: $13,478
Internal Medicine $13,478
Herbert Knight, M.d, M.D
Internal Medicine — Payments: $11,019
Internal Medicine $11,019
Dr. David Haden, M.d, M.D
Internal Medicine — Payments: $9,475
Internal Medicine $9,475
Vera Goode, Md, MD
Internal Medicine — Payments: $8,369
Internal Medicine $8,369
Rajul Malik, Md, MD
Internal Medicine — Payments: $6,478
Internal Medicine $6,478